1. A Study to Evaluate Relative Bioavailability, Food Effect, and Pharmacodynamics of Tropifexor, a Farnesoid X Receptor Agonist, in Healthy Participants. Issue 2 (10th December 2022) Authors: Stringer, Rowan; Chen, Jin; Shah, Bharti; Gu, Jessie; Zhang, Yiming; Prince, William; Klickstein, Lloyd B.; Woessner, Ralph Journal: Clinical pharmacology in drug development Issue: Volume 12:Issue 2(2023) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Drug‐Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects. Issue 11 (12th August 2022) Authors: Chen, Jin; Stringer, Rowan; Shah, Bharti; Gu, Jessie; Zhang, Yiming; Hackling, Melissa; Prince, William; Woessner, Ralph Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 11(2022) Page Start: 1253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗